We use cookies for a better user experience. Read our Privacy Policy

I Agree

Pharmaceutical Intermediates Market Forecast Report, 2021 - 2031

Pharmaceutical Intermediates Market (Product: Bulk Drug Intermediate and Custom Intermediate; Application: Cardiology, Oncology, Endocrinology, Infectious Diseases, Orthopedics, Neurology, Gastroenterology, Dermatology, Inflammatory & Pain Management, Ophthalmology, and Others; and End User: Pharmaceutical & Biotechnology Companies and CROs & CMOs) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2031

Rapidly Growing End-use Industries Boosts Demand for Pharmaceutical Intermediates

Pharmaceutical intermediates are drugs used as raw materials in the production of bulk drugs. Moreover, they are widely used to refer to a material created during the synthesis of an active pharmaceutical ingredient (API) before the processing of becoming an API. Pharmaceutical intermediates are usually formed using high-grade raw materials. These intermediates are widely used in the pharmaceutical and cosmetic industries. The rising demand in these industries is expanding the global pharmaceutical intermediates market. Pharmaceutical intermediates are popularly used for research and development in the pharmaceutical industry. The pharmaceutical intermediates are increasingly being produced using raw materials such as coal tar or petroleum to manufacture pesticides, pharmaceuticals, resins, additives, plasticizers, etc. However, several intermediates can be produced in organic synthesis, and be used in creating various drugs and products. The increasing demand for research and development across the world is propelling the global pharmaceutical intermediates market during the forecast period.

Intermediates can be defined as semi-finished products that are intermediate products of certain products. In simpler words, to produce a product, it can be produced from intermediates to save costs. Pharmaceutical production needs a large number of specific chemicals that were originally produced by the pharmaceutical industry. However, with the expansion of social labor division and the evolution of production technology, the pharmaceutical industry can transfer the production of required pharmaceutical intermediates to chemical enterprises. Pharmaceutical intermediates are exquisite chemical products. The production of pharmaceutical intermediates has grown vastly in the international chemical industry. The growing chemical industry is driving demand for pharmaceutical intermediates across the world. The pharmaceutical intermediates are produced on demand for bulk and custom productions.

pharmaceutical intermediates market infographic

To know the scope of our report Get a Sample on Pharmaceutical Intermediates Market

Lack of Raw Materials Hinders Market Production across Several Industries

The outbreak of the novel COVID-19 disease led to a global pandemic that poses a serious risk to the macro economy through the halt in production activities, interruptions of people's movement, and disruption in supply chains. The crisis has had critical effects on the global healthcare industry and the pharmaceutical sector, which are expected to last long. The pharmaceutical industry will be needing appropriate planning to reduce its socio-economic burden in the upcoming future. As the virus began to spread worldwide in 2020, the pharmaceutical industry supported governments to help provide with the rising demand. Pharmaceutical ingredients raised in demand for research and development of the cure. On the other hand, pharmaceutical sectors struggled to maintain natural market flow, as the pandemic affected the access to essential medicines due to increased consumer storage. With the evaluation of the pharmaceutical system challenges at the global level, the report displays the situation analysis of the pharmaceutical intermediates market in developing countries with emerging pharmaceutical markets.

The spread of the virus has resulted in increased hospitalization with COVID-19 patients that led to a shortage of medicinal storage. Globally, many government authorities announced shortages for several medicines, including the potential treatments for COVID-19. The pandemic can be associated with various short and long-term impacts on the pharmaceutical intermediates market, mainly due to restrictions in the global supply chain resulting in a lack of raw materials. Recognizing these impacts may guide businesses in evidence-informed preparation and decision-making to fight associated difficulties. Various other industries had critical losses with the restrictions in manufacturing and selling. Several end users of pharmaceutical intermediates suffered from shutdowns, project delays, insufficient raw materials, and workforce, etc. Nevertheless, with markets being restored in many countries, and pandemic near its end, end-use industries in the pharmaceutical intermediates market, including CMOs and CROs, are anticipating rise in demand post-COVID-19 pandemic. 

Get a glimpse of the in-depth analysis through our Report Brochure

North America to Dominate Pharmaceutical Intermediates Market

The pharmaceutical industry is constantly unfolding and reshaping itself. Various pharmaceutical organizations and major market players are adapting modifications in pharmaceutical intermediate businesses with their rising demand. As pharmaceutical and chemical activities stretch around the globe, innovations are the key focus of manufacturers, and the demand for pharmaceutical intermediates companies is on the rise. Due to the implementation of standardized pharmaceutical activities, good manufacturing practices (GMP) in pharmaceutical corporations, the global pharmaceutical intermediates market is expected to grow in the upcoming future. Major chemical and pharmaceutical manufacturers compete to capture the positions in the pharmaceutical intermediates market. Fulfilling consumer demand for speed, innovation, low cost, and quality amid rising competition and unpredictable market are focus points. However, the onset of new players is making it difficult to shine, which drives the need for outsourcing chemical services at all points, along the drug development pipeline.

With growing pharmaceutical manufacturers and consumers in the U.S. and Canada, North America is projected to hold a major share of the pharmaceutical intermediate market. In addition, the rising prevalence of several contagious and chronic diseases has raised the demand for pharmaceuticals, which is most likely to promote the growth of the pharmaceutical intermediates market over the projected period. Moreover, the presence of major market players in North America is also contributing to the expansion of the pharmaceutical intermediates market in North America. Furthermore, rise in R&D activities and increase in investments in these activities from governments and major players in Europe are likely to drive the market in North America. Additionally, the improved demand for advanced pharmaceutical products is expected to boost the pharmaceutical intermediates market during the forecast period.

Pharmaceutical Intermediates Market to Witness Moderate Growth in Near Future

The world is witnessing an increasing number of diseases and a rising number of patients every year. In addition, the number of physician visits for infectious and parasitic diseases has rapidly raised in millions, creating the demand for numerous pharmaceutical products. High spending on R&D and advancements in innovative therapies are anticipated to improve the growth rate of the pharmaceutical intermediates market in the near future. However, strict regulatory policies for manufacturers for product quality will slow down the growth rate. Nevertheless, with increase in healthcare expenditure and rise in manufacturer focus on research & development, the global pharmaceutical intermediates market is projected to expand at a CAGR of ~6% from 2021 to 2031.

pharmaceutical intermediates market segmentation

Expanding operations in future? To get the perfect launch ask for a custom report

Analysts' Viewpoint

The demand for pharmaceutical intermediates majorly depends on the rise in the demand for essential drugs to treat chronic diseases. The growing prevalence of contagious diseases, principally in Southeast Asia, is likely to fuel the demand for APIs in the following years, ultimately propelling the pharmaceutical intermediates market. Moreover, advancements in technologies such as high throughput, bioinformatics, and combinatorial chemistry for better drug candidate identification are increasing the demand for pharmaceutical intermediates for research purposes. Hence, owing to rising production and research exercises in the pharmaceutical industry, the usage of pharmaceutical intermediates is expected to witness a constant growth during the projected period.

Pharmaceutical Intermediates Market: Overview

  • This report analyzes the current and future prospects of the global pharmaceutical intermediates market. Rise in prevalence of chronic diseases, focus on research & development by key players and business strategies adopted by key players are the key factors projected to fuel the growth of the global pharmaceutical intermediates market during the forecast period.
  • The report provides an elaborate executive summary, which comprises a snapshot of the various segments of the global pharmaceutical intermediates market. The report also provides information and data analysis of the global pharmaceutical intermediates market about segments based on product, application, end user, and region.
  • The overview section of the report provides detailed qualitative analysis of drivers and restraints affecting the global pharmaceutical intermediates market, along with opportunities in the global market
  • Additionally, the global pharmaceutical intermediates market report includes company profiles and competitive matrix, which provide data about their businesses, product portfolios, and competitive landscape in the global pharmaceutical intermediates market
  • The report includes data analysis on the global pharmaceutical intermediates market attractiveness by region and segments
  • The last section of the report provides quantitative and qualitative analysis on market share of key players operating in the global pharmaceutical intermediates market. It elaborates on the key competitive strategies adopted by the major industry players, thereby presenting a thorough understanding of the competitive scenario in the global pharmaceutical intermediates market.

Pharmaceutical Intermediates Market: Key Segments

  • In terms of product, the global pharmaceutical intermediates market has been bifurcated into bulk drug intermediate and custom intermediate. The bulk drug intermediate segment has been split into chiral intermediate and achiral intermediate.
  • Based on application, the global pharmaceutical intermediates market has been classified into cardiology, oncology, endocrinology, infectious diseases, orthopedics, neurology, gastroenterology, dermatology, inflammatory & pain management, ophthalmology, and others
  • In terms of end user, the global pharmaceutical intermediates market has been divided into pharmaceutical & biotechnology companies and CROs & CMOs. The pharmaceutical & biotechnology segment is likely to dominate the global pharmaceutical intermediates market during the forecast period.
  • The market size and forecast for each of these segments have been provided from 2017 to 2031. The CAGR of respective segment has also been provided for the forecast period from 2021 to 2031, considering 2020 as the base year.

Pharmaceutical Intermediates Market: Regional Outlook

  • In terms of region, the global pharmaceutical intermediates market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, South Korea, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa)
  • The report provides market size and forecast for each region and country/sub-region from 2017 to 2031. Compound annual growth rate (CAGR) of each of these regions and countries have also been provided for the forecast period from 2021 to 2031, considering 2020 as the base year. The pharmaceutical intermediates market study also covers the competitive scenario in these regions.

Companies Mentioned in Report

  • Key players in the global pharmaceutical intermediates market have been profiled based on key aspects such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
  • Major companies profiled in the global pharmaceutical intermediates market report are
    • BASF SE
    • Lonza Group
    • Evonik Industries AG
    • Cambrex Corporation
    • DSM
    • Aceto
    • Albemarle Corporation
    • Vertellus
    • Chemcon Speciality Chemicals Ltd.
    • Chiracon GmbH
    • A. R. Life Sciences Private Limited

Pharmaceutical Intermediates Market – Segmentation

Product
  • Bulk Drug Intermediate
    • Chiral Intermediate
    • Achiral Intermediate
  • Custom Intermediate
Application
  • Cardiology
  • Oncology
  • Endocrinology
  • Infectious Diseases
  • Orthopedics
  • Neurology
  • Gastroenterology
  • Dermatology
  • Inflammatory & Pain Management
  • Ophthalmology
  • Others
End User
  • Pharmaceutical & Biotechnology Companies
  • CROs & CMOs
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Interested in this report?
Get a FREE sample now!

Get Free Sample

*Get Sample Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of pharmaceutical intermediates market?

Pharmaceutical intermediates market to reach valuation of US$ 53.4 Bn by 2031

What is the anticipated CAGR of the pharmaceutical intermediates market in the forecast period?

Pharmaceutical intermediates market is projected to expand at a CAGR of ~6% from 2021 to 2031

What are the key driving factors for the growth of the pharmaceutical intermediates market?

Pharmaceutical intermediates market is driven by rise in healthcare expenditure and focus on research & development

Which region is expected to project the highest market share in the global pharmaceutical intermediates market?

North America is expected to account for a significant share of the global pharmaceutical intermediates market during the forecast period

Who are the key players in the global pharmaceutical intermediates market?

Key players in the global pharmaceutical intermediates market include BASF SE, Lonza Group, Evonik Industries AG, Cambrex Corporation, DSM, Aceto

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Pharmaceutical Intermediates Market

4. Market Overview

    4.1. Introduction

        4.1.1. Segment Definition

    4.2. Market Dynamics

        4.2.1. Drivers

        4.2.2. Restraints

        4.2.3. Opportunities

    4.3. Global Pharmaceutical Intermediates Market Analysis and Forecast, 2017–2031

5. Key Insights

    5.1. COVID-19 Pandemic Impact on Industry (value chain and short / mid / long term impact)

    5.2. Key Industry Events (mergers and acquisitions, new product development, etc.)

    5.3. Pharmaceutical Intermediates Products/Brands List

6. Global Pharmaceutical Intermediates Market Analysis and Forecast, by Product

    6.1. Introduction & Definition

        6.1.1. Key Findings / Developments

    6.2. Global Pharmaceutical Intermediates Market Value Forecast, by Product, 2017–2031

        6.2.1. Bulk Drug Intermediate

            6.2.1.1. Chiral Intermediate

            6.2.1.2. Achiral Intermediate

        6.2.2. Custom Intermediate

    6.3. Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Product

7. Global Pharmaceutical Intermediates Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

        7.1.1. Key Findings / Developments

    7.2. Global Pharmaceutical Intermediates Market Value Forecast, by Application, 2017–2031

        7.2.1. Cardiology

        7.2.2. Oncology

        7.2.3. Endocrinology

        7.2.4. Infectious Diseases

        7.2.5. Orthopedics

        7.2.6. Neurology

        7.2.7. Gastroenterology

        7.2.8. Dermatology

        7.2.9. Inflammatory & Pain Management

        7.2.10. Ophthalmology

        7.2.11. Others

    7.3. Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Application

8. Global Pharmaceutical Intermediates Market Analysis and Forecast, by End-user

    8.1. Introduction & Definition

        8.1.1. Key Findings / Developments

    8.2. Global Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017–2031

        8.2.1. Pharmaceutical & Biotechnology Companies

        8.2.2. CROs & CMOs

    8.3. Global Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user

9. Global Pharmaceutical Intermediates Market Analysis and Forecast, by Region

    9.1. Key Findings

    9.2. Global Pharmaceutical Intermediates Market Value Forecast by Region

        9.2.1. North America

        9.2.2. Europe

        9.2.3. Asia Pacific

        9.2.4. Latin America

        9.2.5. Middle East & Africa

    9.3. Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Region

10. North America Pharmaceutical Intermediates Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. North America Pharmaceutical Intermediates Market Value Forecast, by Product, 2017–2031

        10.2.1. Bulk Drug Intermediate

            10.2.1.1. Chiral Intermediate

            10.2.1.2. Achiral Intermediate

        10.2.2. Custom Intermediate

    10.3. North America Pharmaceutical Intermediates Market Value Forecast, by Application, 2017–2031

        10.3.1. Cardiology

        10.3.2. Oncology

        10.3.3. Endocrinology

        10.3.4. Infectious Diseases

        10.3.5. Orthopedics

        10.3.6. Neurology

        10.3.7. Gastroenterology

        10.3.8. Dermatology

        10.3.9. Inflammatory & Pain Management

        10.3.10. Ophthalmology

        10.3.11. Others

    10.4. North America Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017–2031

        10.4.1. Pharmaceutical & Biotechnology Companies

        10.4.2. CROs & CMOs

    10.5. North America Pharmaceutical Intermediates Market Value Forecast, by Country, 2017–2031

        10.5.1. U.S.

        10.5.2. Canada

    10.6. North America Pharmaceutical Intermediates Market Attractiveness Analysis

        10.6.1. By Product

        10.6.2. By Application

        10.6.3. By End-user

        10.6.4. By Country

11. Europe Pharmaceutical Intermediates Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Europe Pharmaceutical Intermediates Market Value Forecast, by Product, 2017–2031

        11.2.1. Bulk Drug Intermediate

            11.2.1.1. Chiral Intermediate

            11.2.1.2. Achiral Intermediate

        11.2.2. Custom Intermediate

    11.3. Europe Pharmaceutical Intermediates Market Value Forecast, by Application, 2017–2031

        11.3.1. Cardiology

        11.3.2. Oncology

        11.3.3. Endocrinology

        11.3.4. Infectious Diseases

        11.3.5. Orthopedics

        11.3.6. Neurology

        11.3.7. Gastroenterology

        11.3.8. Dermatology

        11.3.9. Inflammatory & Pain Management

        11.3.10. Ophthalmology

        11.3.11. Others

    11.4. Europe Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017–2031

        11.4.1. Pharmaceutical & Biotechnology Companies

        11.4.2. CROs & CMOs

    11.5. Europe Pharmaceutical Intermediates Market Value Forecast by Country/Sub-region, 2017–2031

        11.5.1. Germany

        11.5.2. U.K.

        11.5.3. France

        11.5.4. Spain

        11.5.5. Italy

        11.5.6. Rest of Europe

    11.6. Europe Pharmaceutical Intermediates Market Attractiveness Analysis

        11.6.1. By Product

        11.6.2. By Application

        11.6.3. By End-user

        11.6.4. By Country/Sub-region

12. Asia Pacific Pharmaceutical Intermediates Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Asia Pacific Pharmaceutical Intermediates Market Value Forecast, by Product, 2017–2031

        12.2.1. Bulk Drug Intermediate

            12.2.1.1. Chiral Intermediate

            12.2.1.2. Achiral Intermediate

        12.2.2. Custom Intermediate

    12.3. Asia Pacific Pharmaceutical Intermediates Market Value Forecast, by Application, 2017–2031

        12.3.1. Cardiology

        12.3.2. Oncology

        12.3.3. Endocrinology

        12.3.4. Infectious Diseases

        12.3.5. Orthopedics

        12.3.6. Neurology

        12.3.7. Gastroenterology

        12.3.8. Dermatology

        12.3.9. Inflammatory & Pain Management

        12.3.10. Ophthalmology

        12.3.11. Others

    12.4. Asia Pacific Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017–2031

        12.4.1. Pharmaceutical & Biotechnology Companies

        12.4.2. CROs & CMOs

    12.5. Asia Pacific Pharmaceutical Intermediates Market Value Forecast, by Country/Sub-region, 2017–2031

        12.5.1. China

        12.5.2. Japan

        12.5.3. India

        12.5.4. Australia & New Zealand

        12.5.5. Rest of Asia Pacific

    12.6. Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis

        12.6.1. By Product

        12.6.2. By Application

        12.6.3. By End-user

        12.6.4. By Country/Sub-region

13. Latin America Pharmaceutical Intermediates Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Latin America Pharmaceutical Intermediates Market Value Forecast, by Product, 2017–2031

        13.2.1. Bulk Drug Intermediate

            13.2.1.1. Chiral Intermediate

            13.2.1.2. Achiral Intermediate

        13.2.2. Custom Intermediate

    13.3. Latin America Pharmaceutical Intermediates Market Value Forecast, by Application, 2017–2031

        13.3.1. Cardiology

        13.3.2. Oncology

        13.3.3. Endocrinology

        13.3.4. Infectious Diseases

        13.3.5. Orthopedics

        13.3.6. Neurology

        13.3.7. Gastroenterology

        13.3.8. Dermatology

        13.3.9. Inflammatory & Pain Management

        13.3.10. Ophthalmology

        13.3.11. Others

    13.4. Latin America Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017–2031

        13.4.1. Pharmaceutical & Biotechnology Companies

        13.4.2. CROs & CMOs

    13.5. Latin America Pharmaceutical Intermediates Market Value Forecast, by Country/Sub-region, 2017–2031

        13.5.1. Brazil

        13.5.2. Mexico

        13.5.3. Rest of Latin America

    13.6. Latin America Pharmaceutical Intermediates Market Attractiveness Analysis

        13.6.1. By Product

        13.6.2. By Application

        13.6.3. By End-user

        13.6.4. By Country/Sub-region

14. Middle East & Africa Pharmaceutical Intermediates Market Analysis and Forecast

    14.1. Introduction

        14.1.1. Key Findings

    14.2. Middle East & Africa Pharmaceutical Intermediates Market Value Forecast, by Product, 2017–2031

        14.2.1. Bulk Drug Intermediate

            14.2.1.1. Chiral Intermediate

            14.2.1.2. Achiral Intermediate

        14.2.2. Custom Intermediate

    14.3. Middle East & Africa Pharmaceutical Intermediates Market Value Forecast, by Application, 2017–2031

        14.3.1. Cardiology

        14.3.2. Oncology

        14.3.3. Endocrinology

        14.3.4. Infectious Diseases

        14.3.5. Orthopedics

        14.3.6. Neurology

        14.3.7. Gastroenterology

        14.3.8. Dermatology

        14.3.9. Inflammatory & Pain Management

        14.3.10. Ophthalmology

        14.3.11. Others

    14.4. Middle East & Africa Pharmaceutical Intermediates Market Value Forecast, by End-user, 2017–2031

        14.4.1. Pharmaceutical & Biotechnology Companies

        14.4.2. CROs & CMOs

    14.5. Middle East & Africa Pharmaceutical Intermediates Market Value Forecast, by Country/Sub-region, 2017–2031

        14.5.1. GCC Countries

        14.5.2. South Africa

        14.5.3. Rest of Middle East & Africa

    14.6. Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis

        14.6.1. By Product

        14.6.2. By Application

        14.6.3. By End-user

        14.6.4. By Country/Sub-region

15. Competition Landscape

    15.1. Market Player – Competition Matrix (by tier and size of companies)

    15.2. Market Share Analysis/Ranking, by Company, 2020

    15.3. Company Profiles

        15.3.1. BASF SE

            15.3.1.1. Company Description

            15.3.1.2. Business Overview

            15.3.1.3. Strategic Overview

            15.3.1.4. SWOT Analysis

        15.3.2. Lonza Group

            15.3.2.1. Company Description

            15.3.2.2. Business Overview

            15.3.2.3. Strategic Overview

            15.3.2.4. SWOT Analysis

        15.3.3. Evonik Industries AG

            15.3.3.1. Company Description

            15.3.3.2. Business Overview

            15.3.3.3. Strategic Overview

            15.3.3.4. SWOT Analysis

        15.3.4. Cambrex Corporation

            15.3.4.1. Company Description

            15.3.4.2. Business Overview

            15.3.4.3. Strategic Overview

            15.3.4.4. SWOT Analysis

        15.3.5. DSM

            15.3.5.1. Company Description

            15.3.5.2. Business Overview

            15.3.5.3. Strategic Overview

            15.3.5.4. SWOT Analysis

        15.3.6. Aceto

            15.3.6.1. Company Description

            15.3.6.2. Business Overview

            15.3.6.3. Strategic Overview

            15.3.6.4. SWOT Analysis

        15.3.7. Albemarle Corporation

            15.3.7.1. Company Description

            15.3.7.2. Business Overview

            15.3.7.3. Strategic Overview

            15.3.7.4. SWOT Analysis

        15.3.8. Vertellus

            15.3.8.1. Company Description

            15.3.8.2. Business Overview

            15.3.8.3. Strategic Overview

            15.3.8.4. SWOT Analysis

        15.3.9. Chemcon Speciality Chemicals Ltd.

            15.3.9.1. Company Description

            15.3.9.2. Business Overview

            15.3.9.3. Strategic Overview

            15.3.9.4. SWOT Analysis

        15.3.10. chiracon GmbH

            15.3.10.1. Company Description

            15.3.10.2. Business Overview

            15.3.10.3. Strategic Overview

            15.3.10.4. SWOT Analysis

        15.3.11. A. R. Life Sciences Private Limited

            15.3.11.1. Company Description

            15.3.11.2. Business Overview

            15.3.11.3. Strategic Overview

            15.3.11.4. SWOT Analysis

List of Tables

Table 01: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 02: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017–2031

Table 03: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 04: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 05: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 06: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Region, 2017–2031

Table 07: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 08: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 09: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017–2031

Table 10: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 11: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 12: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 13: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 14: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 15: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017–2031

Table 16: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 17: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 18: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 19: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 20: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 21: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017–2031

Table 22: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 23: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 24: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 25: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 26: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 27: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017–2031

Table 28: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 29: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 30: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

Table 31: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031

Table 32: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Product, 2017–2031

Table 33: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Bulk Drug Intermediate, 2017–2031

Table 34: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 35: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by Application, 2017–2031

Table 36: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, by End-user, 2017–2031

List of Figures

Figure 01: Global Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017–2031

Figure 02: Global Pharmaceutical Intermediates Market Value Share, by Product, 2020

Figure 03: Global Pharmaceutical Intermediates Market Value Share, by Application, 2020

Figure 04: Global Pharmaceutical Intermediates Market Value Share, by End-user, 2020

Figure 05: Global Pharmaceutical Intermediates Market Value Share, by Region, 2020

Figure 06: Global Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031

Figure 07: Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021–2031

Figure 08: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Bulk Drug Intermediate, 2017–2031

Figure 09: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Custom Intermediate, 2017–2031

Figure 10: Global Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031

Figure 11: Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021–2031

Figure 12: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Cardiology, 2017–2031

Figure 13: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Oncology, 2017–2031

Figure 14: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Endocrinology, 2017–2031

Figure 15: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Infectious Diseases, 2017–2031

Figure 16: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Orthopedics, 2017–2031

Figure 17: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Neurology, 2017–2031

Figure 18: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Gastroenterology, 2017–2031

Figure 19: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Dermatology, 2017–2031

Figure 20: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Others, 2017–2031

Figure 21: Global Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031

Figure 22: Global Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021–2031

Figure 23: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Companies, 2017–2031

Figure 24: Global Pharmaceutical Intermediates Market Revenue (US$ Mn), by CROs & CMOs, 2017–2031

Figure 25: Global Pharmaceutical Intermediates Market Value Share Analysis, by Region, 2020 and 2031

Figure 26: Global Pharmaceutical Intermediates Market Attractiveness Analysis, by Region, 2021–2031

Figure 27: North America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017–2031

Figure 28: North America Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 29: North America Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 30: North America Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031

Figure 31: North America Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021–2031

Figure 32: North America Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031

Figure 33: North America Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021–2031

Figure 34: North America Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031

Figure 35: North America Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021–2031

Figure 36: Europe Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017–2031

Figure 37: Europe Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 38: Europe Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 39: Europe Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031

Figure 40: Europe Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021–2031

Figure 41: Europe Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031

Figure 42: Europe Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021–2031

Figure 43: Europe Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031

Figure 44: Europe Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021–2031

Figure 45: Asia Pacific Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017–2031

Figure 46: Asia Pacific Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 47: Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 48: Asia Pacific Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031

Figure 49: Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021–2031

Figure 50: Asia Pacific Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031

Figure 51: Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021–2031

Figure 52: Asia Pacific Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031

Figure 53: Asia Pacific Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021–2031

Figure 54: Latin America Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017–2031

Figure 55: Latin America Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 56: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 57: Latin America Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031

Figure 58: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021–2031

Figure 59: Latin America Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031

Figure 60: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021–2031

Figure 61: Latin America Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031

Figure 62: Latin America Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021–2031

Figure 63: Middle East & Africa Pharmaceutical Intermediates Market Value (US$ Mn) Forecast, 2017–2031

Figure 64: Middle East & Africa Pharmaceutical Intermediates Market Value Share Analysis, by Country/Sub-region, 2020 and 2031

Figure 65: Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis, by Country/Sub-region, 2021–2031

Figure 66: Middle East & Africa Pharmaceutical Intermediates Market Value Share Analysis, by Product, 2020 and 2031

Figure 67: Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis, by Product, 2021–2031

Figure 68: Middle East & Africa Pharmaceutical Intermediates Market Value Share Analysis, by Application, 2020 and 2031

Figure 69: Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis, by Application, 2021–2031

Figure 70: Middle East & Africa Pharmaceutical Intermediates Market Value Share Analysis, by End-user, 2020 and 2031

Figure 71: Middle East & Africa Pharmaceutical Intermediates Market Attractiveness Analysis, by End-user, 2021–2031

Transparency Market Research Plus

Get a free copy if the report you purchased is updated within 90 days

Copyright © Transparency Market Research, Inc. All Rights reserved